Insulin aspart, recombinant Subcutaneous and Pyrilamine and Codeine
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pyrilamine and Codeine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: codeine / pyrilamine
Brand name: Pro-Clear AC
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pyrimethamine
- Insulin aspart, recombinant Subcutaneous-Pyrimethamine and sulfadoxine
- Insulin aspart, recombinant Subcutaneous-Pyrophosphate Injection
- Pyrilamine and Codeine-Insulin degludec
- Pyrilamine and Codeine-Insulin Degludec (U-100) Prefilled Pens
- Pyrilamine and Codeine-Insulin Degludec (U-100) Vials
- Pyrilamine and Codeine-Insulin Degludec (U-200) Prefilled Pens
- Pyrilamine and Codeine-Insulin degludec and liraglutide
- Pyrilamine and Codeine-Insulin degludec and liraglutide Subcutaneous